USYNF yields 226.76% · PFE yields 6.20%● Live data
📍 USYNF pulled ahead of the other in Year 1
Combined, USYNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USYNF + PFE for your $10,000?
Unisync Corp., through its subsidiaries, manufactures and distributes garments in Canada. It operates in two segments, Peerless Garments LP and Unisync Group Limited. The company provides duty gear, footwear, and other accessories to fire, emergency medical services, and police and security sectors under the Carleton brand name; and service wear shirts, pants, and ties for law enforcement, fire, emergency medical, security, and correctional personnel under the Rapier brand name. It also offers professional workwear, insulated coverall, rugged workwear, outerwear, and rainwear apparel, as well as flame-resistant and safety clothing under the Hammill brand name. In addition, the company provides a line of flame-resistant work clothing under the DewLine Coveralls brand name; leatherwear; cold/wet weather outerwear garments to government organizations, including the armed forces, parks and forestry staff, RCMP, and other users under the Parkas brand name; stealth suits to various DND departments, paramilitary, police departments, and companies within the oil industry under the Gore-Tex brand name; and body measurement services under the Best-Fit name. Further, it designs, manufactures, and distributes corporate, public safety, and military uniforms under the Red the Uniform Tailor brand name; and offers corporate apparel under the York brand name, as well as public safety, and security and tactical products. The company was formerly known as ComWest Enterprise Corp. and changed its name to Unisync Corp. in August 2014. Unisync Corp. was founded in 1929 and is headquartered in Vancouver, Canada.
Full USYNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.